Article

COMMENTARY—Technology Is Outstripping Proof


 

References

There is widespread belief among most stroke neurologists that when you have a stroke that looks embolic and you don't have a source, you need to monitor for longer than we have done traditionally. The nuances are really how to do that. This is a great approach; it's a lot easier than wearing a 30-day Holter monitor or having an implanted device, but we have to compare it with other approaches and see what the heart end points really are to know if it's the best approach. I think that everybody in the stroke community appreciates that the more you monitor, the more you are likely to find atrial fibrillation. How long you should monitor, by what technique, and whether monitoring should be continuous or intermittent are unanswered questions. The other question is how much atrial fibrillation is significant. Is a 30-second run significant, or does it need to be minutes at a time? These questions need to be answered before there's a wholesale buy-in for this kind of monitoring for every patient.

Kyra Becker, MD,
Professor of Neurology and
Neurological Surgery,
Director of Vascular
Neurology Services,
Comprehensive Stroke
Center in Seattle,
University of Washington,
Seattle

Recommended Reading

AAN updates botulinum toxin guidelines for most established uses
MDedge Neurology
Endovascular thrombectomy procedure volume for stroke may not affect outcomes
MDedge Neurology
Medical Treatment May Be Safer Than Invasive Treatment for Arteriovenous Malformation
MDedge Neurology
Late-Life Pregnancy Increases Risk of Hemorrhagic Stroke
MDedge Neurology
Can Natalizumab Improve Stroke Recovery?
MDedge Neurology
Prevent Stroke, Prevent Dementia?
MDedge Neurology
Cardiovascular Health May Prevent Cognitive Decline
MDedge Neurology
Idarucizumab May Reverse Dabigatran Anticoagulation in Intracranial Hemorrhage
MDedge Neurology
Treatment With t-PA Reduces Mortality After Intraventricular Hemorrhage
MDedge Neurology
Extended Holter Monitoring Improves Detection of Atrial Fibrillation
MDedge Neurology

Related Articles